The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).
BACKGROUND: There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC2916843?pdf=render |
| _version_ | 1818189997715488768 |
|---|---|
| author | Johannes Brettschneider Anne Czerwoniak Makbule Senel Lubin Fang Jan Kassubek Elmar Pinkhardt Florian Lauda Tamara Kapfer Sarah Jesse Vera Lehmensiek Albert C Ludolph Markus Otto Hayrettin Tumani |
| author_facet | Johannes Brettschneider Anne Czerwoniak Makbule Senel Lubin Fang Jan Kassubek Elmar Pinkhardt Florian Lauda Tamara Kapfer Sarah Jesse Vera Lehmensiek Albert C Ludolph Markus Otto Hayrettin Tumani |
| author_sort | Johannes Brettschneider |
| collection | DOAJ |
| description | BACKGROUND: There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as a prognostic marker in patients with clinically isolated syndrome (CIS) regarding conversion to MS, and to compare it to Barkhof criteria in magnetic resonance imaging (MRI), oligoclonal bands (OCB) and the polyspecific intrathecal B cell response against measles, rubella and varicella zoster virus (MRZR). METHODOLOGY/PRINCIPAL FINDINGS: CXCL13 was determined in a prospective study over 2 years including 46 patients that remained CIS over follow-up (CIS-CIS), 45 patients that developed MS (CIS-RRMS), and 30 controls using ELISA. CSF CXCL13 was significantly elevated in CIS-RRMS as compared to CIS-CIS and controls (p<0.001). It was significantly elevated in CIS with OCB (p<0.001), positive MRZR (p=0.04), and gadolinium enhancement in MRI (p=0.02) and showed a significant correlation with CSF leukocyte count (p<0.001) and QIgG (p<0.001). CXCL13 showed the best positive predictive value (PPV) of all parameters investigated (70%, 95%-CI: 53-84%), which could be further increased by combination with Barkhof criteria in MRI (80%). CONCLUSIONS/SIGNIFICANCE: Our data indicate the relevance of CXCL13 in CIS to predict conversion to MS. It furthermore shows CXCL13 to be an important mediator in the inflammatory cascade associated with the polyspecific intrathecal B cell response that manifests itself in OCB and MRZR. |
| first_indexed | 2024-12-11T23:51:43Z |
| format | Article |
| id | doaj.art-eb2aeed1701b47af9a916096b56020ed |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T23:51:43Z |
| publishDate | 2010-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-eb2aeed1701b47af9a916096b56020ed2022-12-22T00:45:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-01-0158e1198610.1371/journal.pone.0011986The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).Johannes BrettschneiderAnne CzerwoniakMakbule SenelLubin FangJan KassubekElmar PinkhardtFlorian LaudaTamara KapferSarah JesseVera LehmensiekAlbert C LudolphMarkus OttoHayrettin TumaniBACKGROUND: There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as a prognostic marker in patients with clinically isolated syndrome (CIS) regarding conversion to MS, and to compare it to Barkhof criteria in magnetic resonance imaging (MRI), oligoclonal bands (OCB) and the polyspecific intrathecal B cell response against measles, rubella and varicella zoster virus (MRZR). METHODOLOGY/PRINCIPAL FINDINGS: CXCL13 was determined in a prospective study over 2 years including 46 patients that remained CIS over follow-up (CIS-CIS), 45 patients that developed MS (CIS-RRMS), and 30 controls using ELISA. CSF CXCL13 was significantly elevated in CIS-RRMS as compared to CIS-CIS and controls (p<0.001). It was significantly elevated in CIS with OCB (p<0.001), positive MRZR (p=0.04), and gadolinium enhancement in MRI (p=0.02) and showed a significant correlation with CSF leukocyte count (p<0.001) and QIgG (p<0.001). CXCL13 showed the best positive predictive value (PPV) of all parameters investigated (70%, 95%-CI: 53-84%), which could be further increased by combination with Barkhof criteria in MRI (80%). CONCLUSIONS/SIGNIFICANCE: Our data indicate the relevance of CXCL13 in CIS to predict conversion to MS. It furthermore shows CXCL13 to be an important mediator in the inflammatory cascade associated with the polyspecific intrathecal B cell response that manifests itself in OCB and MRZR.http://europepmc.org/articles/PMC2916843?pdf=render |
| spellingShingle | Johannes Brettschneider Anne Czerwoniak Makbule Senel Lubin Fang Jan Kassubek Elmar Pinkhardt Florian Lauda Tamara Kapfer Sarah Jesse Vera Lehmensiek Albert C Ludolph Markus Otto Hayrettin Tumani The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS ONE |
| title | The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). |
| title_full | The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). |
| title_fullStr | The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). |
| title_full_unstemmed | The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). |
| title_short | The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). |
| title_sort | chemokine cxcl13 is a prognostic marker in clinically isolated syndrome cis |
| url | http://europepmc.org/articles/PMC2916843?pdf=render |
| work_keys_str_mv | AT johannesbrettschneider thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT anneczerwoniak thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT makbulesenel thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT lubinfang thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT jankassubek thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT elmarpinkhardt thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT florianlauda thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT tamarakapfer thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT sarahjesse thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT veralehmensiek thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT albertcludolph thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT markusotto thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT hayrettintumani thechemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT johannesbrettschneider chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT anneczerwoniak chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT makbulesenel chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT lubinfang chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT jankassubek chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT elmarpinkhardt chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT florianlauda chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT tamarakapfer chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT sarahjesse chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT veralehmensiek chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT albertcludolph chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT markusotto chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis AT hayrettintumani chemokinecxcl13isaprognosticmarkerinclinicallyisolatedsyndromecis |